Differential Endocrine and Metabolic Effects of Testosterone Suppressive Agents in Transgender Women
- 1 August 2020
- journal article
- research article
- Published by Elsevier BV in Endocrine Practice
- Vol. 26 (8), 883-890
- https://doi.org/10.4158/ep-2020-0032
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Endocrine Treatment of Male-to-Female Transsexuals Using Gonadotropin-Releasing Hormone AgonistExperimental and Clinical Endocrinology & Diabetes, 2005
- Progestogens in hormonal replacement therapy: new molecules, risks, and benefitsMenopause, 2002
- Cellular receptors for sex steroids in human pituitary adenomasJournal of Endocrinology, 1996
- The Long-Term Use of Cyproterone Acetate in Pedophilia: A Case StudyJournal of Sex & Marital Therapy, 1992
- Morphofunctional study of the effects of fetal exposure to cyproterone acetate on the hypothalamo-pituitary-gonadal axis of adult ratsExperimental Brain Research, 1991
- Mortality and morbidity in transsexual patients with cross-gender hormone treatmentMetabolism, 1989
- Clinical and endocrine effects of cyproterone acetate in postmenopausal patients with advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- The Effect of Cyproterone Acetate Alone and in Combination with Ethinylestradiol on the Hypothalamic Pituitary Adrenal Axis, Prolactin and Growth Hormone Release in Male-to-Female TranssexualsHormone and Metabolic Research, 1986
- Cyproterone acetate, testosterone, LH, FSH, and prolactin levels in plasma after intramuscular application of cyproterone acetate in patients with prostatic cancerThe Prostate, 1981
- Effect of cyproterone acetate on prolactin secretion in the female rhesus monkeyCell and tissue research, 1977